GC70467
BCI-137
Also known as 2-[(2,3-dioxo-1,4-dihydroquinoxalin-6-yl)sulfonylamino]propanoic acid
BCI-137 is a competitive AGO2 inhibitor, with an IC50 of 342 μM
ChemicalCAS112170-24-8MW313.29FormulaC11H11N3O6S
- CAS number
- 112170-24-8
- Molecular weight
- 313.29
- Formula
- C11H11N3O6S
- Solubility
- DMSO ： 100 mg/mL (319·19 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
- InChIKey
- VMSRTLYZOWBBFW-UHFFFAOYSA-N
- Catalogue number
- GC70467
- Brand
- GLPBIO
Computed properties PubChem CID 3157172 · XLogP -0.6 · TPSA 150 Ų · H-bond donors 4
- XLogP
- -0.6
- TPSA
- 150 Ų
- H-bond donors
- 4
- H-bond acceptors
- 7
- Rotatable bonds
- 4
- Heavy atoms
- 21
SMILES CC(C(=O)O)NS(=O)(=O)C1=CC2=C(C=C1)NC(=O)C(=O)N2
Computed descriptors from PubChem (CID 3157172), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il